Cargando…
Enzyme replacement therapy and white matter hyperintensity progression in Fabry disease
OBJECTIVE: To explore the association between enzyme replacement therapy (ERT), clinical characteristics, and the rate of progression of white matter hyperintensities (WMH) in patients with Fabry disease (FD). METHODS: Patients with a confirmed diagnosis of FD, aged 18 years or older, participating...
Autores principales: | Stefaniak, James D., Parkes, Laura M., Parry-Jones, Adrian R., Potter, Gillian M., Vail, Andy, Jovanovic, Ana, Smith, Craig J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177273/ https://www.ncbi.nlm.nih.gov/pubmed/30209238 http://dx.doi.org/10.1212/WNL.0000000000006316 |
Ejemplares similares
-
White matter hyperintensities and neurodegenerative dementias
por: Sassi, Celeste
Publicado: (2019) -
Progression of White Matter Hyperintensities Contributes to Lacunar Infarction
por: Xu, Xin, et al.
Publicado: (2018) -
The Impact of Intracerebral Hemorrhage on the Progression of White Matter Hyperintensity
por: Chen, Xuemei, et al.
Publicado: (2018) -
White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy
por: Fiford, Cassidy M., et al.
Publicado: (2017) -
White matter hyperintensity in different migraine subtypes
por: Dobrynina, L. A., et al.
Publicado: (2021)